Amantadine-HCL treatment of chronic hepatitis C in non-responders to alpha-interferon.

被引：0
|
作者：
Parolin, MB [1 ]
Lacerda, MA [1 ]
Lopes, RW [1 ]
机构：
[1] Univ Fed Parana, Div Gastroenterol Hepatol, BR-80060000 Curitiba, Parana, Brazil
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2208
引用
收藏
页码：714A / 714A
页数：1
相关论文
共 50 条
  • [1] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [2] Interferon/ribavirin treatment in interferon non-responders with chronic hepatitis C.
    Teuber, G
    Berg, T
    Leidig, L
    Hoffmann, RM
    Lafrenz, M
    Spengier, U
    Hopf, U
    Zeuzem, S
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [3] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [4] Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders
    Hasan, F
    Asker, H
    Al Shamali, M
    Al Kalaoui, M
    Al Nakib, B
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1642 - 1644
  • [5] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
  • [6] Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C - A randomised, controlled pilot study
    Wenger, Christa
    Bischof, Thomas
    Gonvers, Jean-Jacques
    Renner, Eberhard L.
    Mullhaupt, Beat
    SWISS MEDICAL WEEKLY, 2007, 137 (29-30) : 418 - 423
  • [7] Induction treatment of chronic hepatitis C with daily interferon plus ribavirin plus amantadine is effective in non-responders to interferon plus ribavirin
    Stauber, R
    Munda-Steindl, P
    Hackl, F
    Schüutze, K
    Datz, C
    Hofer, H
    Hegenbarth, K
    Jessner, W
    Ferenci, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 134 - 135
  • [8] Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Hoffmann, RM
    Leifeld, L
    Lafrenz, M
    Spengler, U
    Pape, GR
    Hopf, U
    Zeuzem, S
    DIGESTION, 2000, 61 (02) : 90 - 97
  • [9] Interferon alpha-2a in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy
    Salmeron, J
    Diago, M
    Andrade, R
    Perez, R
    Sola, R
    Romero, M
    De La Mata, M
    Granados, R
    Torrente, V
    Aguilar, J
    Planas, R
    Perez-Moreno, J
    Casanovas, T
    JOURNAL OF HEPATOLOGY, 2003, 38 : 168 - 168
  • [10] A controlled study of amantadine monotherapy vs. amantadine combined with interferon-α in chronic hepatitis C patients non-responders to interferon-α.
    El-Zayadi, A
    Selim, O
    Shawky, S
    Moustafa, H
    El-Taweel, A
    HEPATOLOGY, 1998, 28 (04) : 473A - 473A
12345